Skip to main content

TJO

ApplicationSalt Lake City, Utah, United StatesFounded 2009· One of 687 Application companies tracked by AMPulse

Salt Lake City medical device company that designs and sells hip and knee replacement implants with reduced-tray instrumentation, and plans to expand additive manufacturing with supply partners.

CEO / Founder
Erin Hofmann
Team Size
11-50
Stage
Active
Total Funding
$15.6M
Latest Round
Debt
Key Investors
Wells Fargo

Technology & Products

Key Products

Klassic Knee System (modern universal femoral design, single-tray primary workflow); Klassic Knee Revision System with Universal Cone System; Klassic HD Hip System; Platform Hip / Platform Acetabular System; Aurum Technology (ballistically bonded titanium nitride surface); Klassic ONE instrumentation; PS-Max tibial insert.

Technological Advantage

Streamlined system architecture reducing inventory and instrument complexity; Aurum TiN surface for metal-sensitive patients; ASC-aligned economics (32% of 2026 YTD procedures in ASCs); compatibility with THINK Surgical TMINI robotic system. Additive manufacturing is outsourced to supply partners; specific printed components and processes are undisclosed.

Differentiation

Value Proposition

Efficiency by Design platform: hip and knee implant systems requiring a maximum of three instrument trays per procedure, cutting sterilization burden, storage cost and OR turnover time, suited to ambulatory surgery centers.

How They Differentiate

Fewer instrument trays and universal femoral design versus multi-tray, side-specific systems from large incumbents; cobalt-chrome reduction strategy via Aurum TiN surface; ASC-focused cost positioning.

Market & Competition

Target Customers

Orthopedic surgeons, hospitals and ambulatory surgery centers (ASCs) performing total joint arthroplasty in the United States.

Industry Verticals

Medical devices; orthopedic joint replacement (hip and knee arthroplasty).

Competitors

Zimmer Biomet; Stryker; Smith & Nephew

Growth & Milestones

Growth Metrics

55,000+ implants placed nationwide including 42,000+ Klassic Knee implants (Oct 2026); 32% of 2026 YTD procedures performed in ASCs.

Major Milestones

2009 founded; 2013 modern universal femoral component introduced; 2022 Klassic Knee with Aurum Technology launched; surpassed 20,000 Klassic Knee implants; THINK Surgical collaboration; FDA clearance for Klassic Knee cemented femoral stem; surpassed 50,000 implants; Oct 2026 secured up to $11M Wells Fargo debt facility to fund inventory, distribution, next-gen hip stem, porous/revision Aurum designs and expanded additive manufacturing.

Recent coverage of TJO

Funding rounds

  • Debtup to $11M2026-10Lead: Wells Fargo · Source
  • Series A$2M2014-02Source
  • Series A$2.6M2012-02Source